Streetbeat News

DCGO

DocGo Inc.

https://www.docgo.com

Industry

Medical - Care Facilities

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Open

2.93

Mkt cap

291M

Volume

1.1M

High

3.00

P/E Ratio

15.83

52-wk high

5.67

Low

2.75

Div yield

N/A

52-wk low

2.75

DocGo reported better-than-expected Q2 revenue results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:31 pm

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 10:10 am

Several healthcare stocks experienced significant movement in Monday's after-market session. Notable gainers included Vivos Therapeutics (VVOS), Cardiff Oncology (CRDF), T2 Biosystems (TTOO), Hims & Hers Health (HIMS), Etao International Co (ETAO), and Bionomics (BNOX). On the other hand, Maravai LifeSciences (MRVI), ICU Medical (ICUI), RenovoRx (RNXT), Mallinckrodt (MNK), Gracell Biotechnologies (GRCL), and DocGo (DCGO) saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 9:32 pm

DocGo (NASDAQ:DCGO) reported Q2 earnings per share of $(0.02), missing the analyst consensus estimate of $0.03 by 166.67%. This is a 118.18% decrease from the same period last year. However, the company's quarterly sales of $125.49 million beat the analyst consensus estimate of $119.64 million by 4.89%, marking a 14.58% increase from the same period last year.

Portfolio Pulse from sunil@benzinga.com

August 07, 2023 | 8:39 pm

DocGo (NASDAQ:DCGO) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $0.03. The company's past performance shows a pattern of share price changes following earnings reports. Shares of DocGo were trading at $8.7 as of August 3, with a 2.4% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 3:44 pm

Over the last quarter, DocGo (NASDAQ:DCGO) has received four bullish ratings from analysts. The 12-month price target for DocGo, according to these analysts, averages at $12.75, with a high of $14.00 and a low of $12.00. This average price target has seen an increase of 6.25% over the past month.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 4:00 pm

Stifel analyst David Grossman has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 3:56 pm

DocGo has announced the expansion of its partnership with Healthcare Partners NY. The program is expected to help thousands of patients in 2023.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 11:56 am

Stifel analyst David Grossman reiterated a Buy rating on DocGo (NASDAQ:DCGO) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

June 21, 2023 | 1:39 pm

Canaccord Genuity analyst Richard Close reiterated a Buy rating on DocGo (NASDAQ:DCGO) and maintained a $13 price target.

Portfolio Pulse from richadhand@benzinga.com

June 21, 2023 | 1:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.